When we generated a CCL5 knockdown H22 cell line and implant to tumor bearing mice, the tumor weight in shRNA CCL5-Ctrl mice was higher than shRNA Ctrl-Ctrl, which suggested CCL5 may have an anti-tumor effect (Figure 5D). This evidence concerns the gene CCL5 and neoplasm.